Mucopolysaccharidosis Type VII

DBCOND0063470Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesNutritional and Metabolic Diseases

Mucopolysaccharidosis Type VII is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Mucopolysaccharidosis VII · Sly Syndrome · Mucopolysaccharidosis Type 7 · MPS VII · Sly Disease
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0025240ICD-10E76.29SNOMED CT124470009MedDRA10056893UMLSC0085132

What you can answer from here — as of November 03, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
10Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Mucopolysaccharidosis Type VII share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In